BIOSANTE PHARMACEUTICALS INC 4/A
4/A · BIOSANTE PHARMACEUTICALS INC · Filed Oct 22, 2004
Insider Transaction Report
Form 4/AAmended
ROSENOW EDWARD C III
Director
Transactions
- Exercise/Conversion
Common Stock
2004-10-15$2.85/sh+5,000$14,250→ 17,539 total - Exercise/Conversion
Stock Option (right to buy)
2004-10-15$2.85/sh−5,000$14,250→ 0 totalExercise: $2.85From: 2000-10-27Exp: 2004-10-27→ Common Stock (5,000 underlying)